Levin Capital Strategies, L.P. Merck & Co., Inc. Transaction History

Levin Capital Strategies, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$73.51 - $82.4 $147,020 - $164,800	-2,000 Reduced 30.84%	4,485 $368,000
Q4 2021 Feb 15, 2022	BUY	$72.28 - $90.54 $148,896 - $186,512	2,060 Added 46.55%	6,485 $497,000
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $31,682 - $34,842	-442 Reduced 9.08%	4,425 $332,000
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $6.53 Million - $7.22 Million	-92,810 Reduced 95.02%	4,867 $379,000
Q1 2021 May 05, 2021	SELL	$68.86 - $81.11 $541,790 - $638,173	-7,868 Reduced 7.45%	97,677 $7.53 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $7.21 Million - $8 Million	100,444 Added 1969.1%	105,545 $8.63 Million
Q3 2020 Nov 17, 2020	BUY	$73.18 - $82.95 $373,291 - $423,127	5,101 New	5,101 $423,000
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $293,001 - $334,184	-4,211 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$65.24 - $75.71 $142 Million - $165 Million	-2,175,371 Reduced 99.81%	4,211 $322,000
Q3 2018 Oct 29, 2018	SELL	$57.69 - $67.84 $8.87 Million - $10.4 Million	-153,693 Reduced 6.59%	2,179,582 $155 Million
Q2 2018 Aug 07, 2018	BUY	$50.83 - $59.72 $7.68 Million - $9.02 Million	151,076 Added 6.92%	2,333,275 $142 Million
Q1 2018 May 18, 2018	BUY	$50.96 - $59.23 $64.8 Million - $75.3 Million	1,271,780 Added 139.69%	2,182,199 $119 Million
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $12.4 Million - $14.8 Million	239,878 Added 35.77%	910,419 $51.2 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $39.3 Million - $42.3 Million	670,541	670,541 $42.9 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

Stay updated on Levin Capital Strategies, L.P. with notifications on news.